BioCentury
ARTICLE | Company News

Avant, Megan Health Inc., Pfizer deal

December 4, 2000 8:00 AM UTC

AVAN will purchase Megan for 1.9 million AVAN shares valued at $14.3 million. AVAN said the acquisition adds to its vaccines portfolio, including technology for developing vaccines against Campylobact...